Recruitment of neutrophils into alveolar air spaces is an early event in the pathogenesis
sequence [3] . The specific effects of chemokines on their target cells are mediated by members of a family of 7-transmembrane-spanning, G-protein-coupled receptors [4] . Chemokines containing the ELR motif, including CXCL1-3 (growth-related oncogene [GRO]-a, GRO-b, and GRO-g) and CXCL5-8 (epithelial neutrophil-activating protein [ENA]-78, granulocyte chemotactic protein [GCP]-2, neutrophil activating protein [NAP]-2, and interleukin [IL]-8) are potent neutrophil chemoattractants and principally exert their effects by binding to chemokine receptors CXCR1 and CXCR2 expressed on neutrophils [3] . Most cell types and tissues can be induced to secrete 1 or, more often, an array of chemokines, and increased expression of chemokines has been observed in several bacterial disease states [5] . There is mounting evidence that chemokines play an important role in the initial stages of inflammation observed in bacterial pneumonia. Increased levels of the chemokines CXCL1 (GRO-a) and CXCL8 (IL-8), and the neutrophil activation products elastase and myeloperoxidase, have been found in bronchoalveolar lavage fluid obtained from patients with bacterial pneumonia and chronic bronchitis [6, 7] . Standiford et al. [8] and Greenberger et al. [9] have described the chemokine profile induced in murine models of pneumonia caused by gram-negative organisms and have shown that passive immunization against macrophage inhibitory protein 2 (MIP-2), the mouse homologue of CXCL8, renders mice susceptible to pneumonia due to Klebsiella pneumoniae.
The surface of S. pneumoniae is decorated with proteins, such as pneumococcal surface antigen A (PsaA) and pneumococcal surface protein A (PspA), which have been shown to be virulence factors [10] . Another family of cell surface proteins, termed choline-binding proteins (CbpA-CbpJ), are noncova-lently bound to phosphocholine present in the teichoic and lipoteichoic acid of the cell membrane and cell wall [10] . A number of these proteins have been found to play a role in nasopharyngeal colonization of S. pneumoniae, and CbpG appears to have a role in pneumococcal-mediated sepsis [11, 12] .
CbpA (also designated PspC, SpsA, and Hic) [13] [14] [15] , as well as being a component of the pneumococcal cell wall, also has been shown to be secreted by pneumococci [11] . CbpA has a number of biologic functions that may modulate the immune response to S. pneumoniae. These functions include binding to the secretory component of secretory IgA [14] , the complement protein C3 [16] , and human factor H [15, 17] , as well as playing a major role in pneumococcal adherence and colonization of the nasopharyngeal respiratory airways [11] . CbpA has been shown recently to facilitate invasion into and through nasopharyngeal epithelial cells by interacting with the human polymeric immunoglobulin receptor [18] . Brooks-Walter et al. [13] found that the gene for CbpA could be detected in ∼75% of all S. pneumoniae strains tested, and comparisons of published sequences for CbpA genes from different pneumococcal strains suggest that CbpA can be separated into 2 distinct clades (A or B), depending on differences in gene structure.
A recent study by Madsen et al. [19] demonstrated that CbpA purified from CP1200, a strain derived from the unencapsulated laboratory strain Rx, could stimulate pulmonary alveolar epithelial cells to secrete CXCL8, which suggests a possible mechanism for chemokine production by respiratory epithelium in response to pneumococci. We previously showed that soluble factors released by exponentially growing pneumococci up-regulate the expression of intercellular adhesion molecule 1 (ICAM-1; an adhesion molecule that has a key role in the adhesion of leukocytes to endothelial and epithelial cell surfaces) on the surface of A549 alveolar epithelial cells and also promote adhesion of neutrophils to these cells [20] . In this study, we demonstrate mRNA transcription and protein production of several chemokines in response to CbpA and investigate differential chemokine induction by clade A and clade B CbpA. We also show that CbpA up-regulates ICAM-1 expression on type II alveolar epithelial cells. 14) and C120 (type 6B) were obtained from nasopharyngeal swabs from pediatric subjects. Capsular types 14 and 6B were studied, because they are very common disease and carriage serotypes [21] . All strains were grown routinely in Todd-Hewitt broth (Oxoid) supplemented with 0.5% yeast extract (THY) at 37ЊC in an atmosphere of 5% CO 2 without shaking. Heat-killed pneumococci were prepared by growing cultures to exponential phase (absorbance at 620 nm [A 620 ] of 0.4-0.5, equivalent to ∼10 8 cfu/mL). Bacteria then were pelleted by centrifugation at 10,000 g for 5 min, were resuspended in 50% (vol/ vol) DMEM-Ham's F12 medium, and were heated at 100ЊC for 20 min. Lack of viability was confirmed by inoculation on blood agar plates with overnight incubation at 37ЊC.
Materials and Methods

Cell
Preparation of secreted pneumococcal proteins and recombinant CbpA. Secreted pneumococcal proteins were collected by growing pneumococci in THY to exponential phase (A 620 , 0.4-0.5, equivalent to ∼10 8 cfu/mL). Two-milliliter aliquots of exponentially growing cultures were subjected to centrifugation at 10,000 g for 5 min. The supernatant was removed from the bacterial pellet, concentrated (Vivascience), dialyzed against PBS overnight at 4ЊC, and stored at Ϫ20ЊC. An aliquot of concentrated supernatants was subjected to 10% SDS-PAGE analysis by use of standard procedures. The proteins were transferred to a nitrocellulose membrane by use of electroblotting, according to the manufacturer's instructions (Bio-Rad). The blots were blocked with 10% blotting-grade dry milk (Bio-Rad) in Tris-buffered saline with 0.05% Tween 20 (TBS-T) for 1 h at room temperature before incubation with mouse polyclonal antiserum to CbpA or to PspA (diluted 1:5000; gifts of James Paton, Adelaide University, Adelaide, Australia) for 2 h. After washing, the blots were incubated with biotinylated goat anti-mouse IgG (diluted 1: 20,000; Sigma) for 1.5 h. Extravidin-alkaline phosphatase (1:30,000; Sigma) then was added and incubated for 1.5 h. All the above reagents were diluted in TBS-T, and incubation steps were at room temperature with gentle shaking on a rocker platform. Blots were developed with color development buffer (Bio-Rad) containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate on a rocker at room temperature. The color reaction was stopped with deionized water when protein bands became clear. Before use in stimulation experiments, concentrated supernatants were reconstituted to 2 mL in serum-free 50% (vol/vol) DMEM-Ham's F12 medium. In all experiments, sterile THY was used as a control. Recombinant truncated CbpA (lacking the choline-binding region) and recombinant PsaA, generated as His-tagged proteins from the clade B CbpA gene by use of an Escherichia coli expression system [22] , were purchased from James Paton (Adelaide University, Adelaide, Australia). Both recombinant proteins were generated from capsular type 2 strain D39, were reconstituted in 50% (vol/vol) glycerol-PBS, and were stored at Ϫ20ЊC.
CbpA polymerase chain reaction (PCR). Primers ABW13 (5 -CGACGAATAGCTGAAGAGG-3 ) and SKH2 (5 -CATACCGT-TTTCTTGTTTCCAGCC-3 ) [13] were used to amplify DNA directly from individual colonies of each strain of S. pneumoniae, which were grown overnight on blood agar plates. The PCR made use of 2 U of Hot Star Taq polymerase (Qiagen) and 1 mM each primer in a reaction volume of 50 mL. Primer ABW13 specifically anneals to a region of DNA upstream of the promoter sequence ), culture supernatants from the same strain ( ), 0.1 n p 6 n p 8 ng/mL of recombinant interleukin (IL)-1a ( ), or untreated (media n p 6 alone, ) for 4 h at 37ЊC. Culture supernatants were harvested, and n p 6 CXCL8 concentrations were measured in duplicate by ELISA. Data are . mean ‫ע‬ SE of the CbpA gene locus, and the SKH2 primer binds to nucleotides that are specific to DNA encoding the C-terminal end of the proline-rich region of the CbpA gene. These primers allow for differentiation between clades A and B of CbpA. Clade A molecules generate PCR products of ∼2.0 kb, whereas clade B molecules generate PCR products of ∼1.5 kb [13] . For PCR, the Taq polymerase was activated after heating the samples for 1 cycle of 15 min at 95ЊC. Samples then were subjected to a total of 25 cycles, each cycle consisting of 30 s at 95ЊC, 45 s at 59ЊC, and 90 s at 72ЊC, which was followed by a further extension cycle of 72ЊC for 8 min. PCR products were visualized on a 1% agarose gel containing ethidium bromide under UV illumination.
A549 cell stimulation experiments.
For stimulation experiments, the media from confluent monolayers were removed, and cells were washed twice with serum-free medium. Cells were stimulated with heat-killed pneumococci, pneumococcal supernatants, recombinant CbpA, or recombinant PsaA. IL-1a (Peprotech) was used as a positive control stimulator of chemokine production. All stimulants were made up in serum-free, antibiotic-free 50% (vol/ vol) DMEM-Ham's F12 medium, and 1 mL was added to each well. Cultures then were incubated for a specified time period at 37ЊC in an atmosphere of 5% CO 2 . After incubation, culture supernatants were collected, were centrifuged at 10,000 g for 5 min to remove cellular debris, and were stored at Ϫ20ЊC. Concentrations of CXCL1 (GRO-a), CXCL5 (ENA-78), CXCL8 (IL-8), and CCL2 (monocyte chemoattractant protein 1) in the supernatants were determined by sandwich ELISA (Quantikine; R&D Systems).
In initial experiments, cell viability after exposure to stimulants was assessed by staining A549 monolayers with propidium iodide and Hoechst 33428 (Molecular Probes) for 5 min at room temperature in the dark. Monolayers were examined microscopically by use of a Leica DM IRB inverted fluorescence microscope.
Total RNA isolation and RNase protection assay. Total RNA was isolated with Trizol reagent (Invitrogen), according to the manufacturer's instructions. Total RNA was dissolved in RNase-free water, and the RNA was quantified and assessed for purity by spectrophotometric analysis at 260 and 280 nm. RNase protection assays were done by use of a kit purchased from BD PharMingen. In brief, total RNA was isolated from stimulated and unstimulated A549 cells, as described above. Multiprobe hCK-5, which contains templates for the chemokines CXCL8, CXCL10, XCL1, and CCL1-5 and the housekeeping genes L-32 and GDPH, was labeled with [a-32 P]UTP (Amersham) by use of T7 RNA polymerase. Labeled probe was hybridized to 3 mg of total RNA for 16 h at 56ЊC. Human RNA obtained from cytokine-stimulated MOLT4 cells was used as a control (BD PharMingen). mRNA probe hybrids were treated with RNase mixture and were extracted with phenol-chloroform. Protected hybrids were resolved on a denaturing polyacrylamide sequencing gel and were exposed to radiographic film for 2 days before being developed.
ICAM-1 (CD54) immunoassay. A549 cells were plated in 96-well plates at cells/well in 50% (vol/vol) DMEM-Ham's 4 5 ϫ 10 F12 medium supplemented with 2 mM L-glutamine and 5% fetal calf serum, and the plates were incubated overnight at 37ЊC in 5% CO 2 . Cells then were washed twice with serum-free media, and triplicate wells were stimulated with 10 mg/mL of recombinant CbpA or recombinant PsaA, 0.1 ng/mL of IL-1a, or carrier control for 16-18 h at 37ЊC with 5% CO 2 . Cells were washed twice with PBS, fixed with 2% paraformaldehyde for 10 min at room temperature, washed twice with PBS, and then blocked with 5% nonfat milk in PBS for р1 h. Monolayers then were incubated with mouse anti-ICAM-1 (Dako) in PBS with 2% bovine serum albumin for 1 h at room temperature, followed by anti-mouse IgG-peroxidase conjugate (Sigma) for 30 min at room temperature. Color was developed with SigmaFast o-phenylenediamine substrate (Sigma) for 30 min, and the optical density was read at 450 nm.
Statistical analysis. All experimental results are expressed as . Data were subjected to normality tests and then anamean ‫ע‬ SE lyzed with Student's t tests to test for significant differences within experiments and 1-way analysis of variance to compare 12 groups of data. A Bonferroni adjustment was applied to final P values to compensate for multiple comparisons. Differences were deemed to be significant if after the corrections had been applied. P р .05
Results
Production of CXCL8 by A549 cells in response to heat-inactivated SSI SP14/1 and secreted proteins. A549 monolayers were stimulated with ∼10
8 cfu/mL heat-killed S. pneumoniae strain SSI SP14/1 (type 14), proteins secreted by 10 8 cfu/mL of this strain during exponential growth, or 0.1 ng/mL of IL-1a, as a positive control, for 4 h at 37ЊC. A549 cells stimulated with heat-killed bacteria produced significantly more CXCL8 ( pg/mL) than did unstimulated controls ( 137.4 ‫ע‬ 32.1 50.0 ‫ע‬ pg/mL; ; ). However, culture supernatants dra-13.9 P ! .05 n p 6 matically increased the secretion of CXCL8 to 1417.2 ‫ע‬ 159.4 pg/mL ( ), a 28-fold increase from unstimulated levels n p 8 ( ; figure 1) . Culture supernatant-induced CXCL8 pro-P ! .001 duction increased over time to reach pg/mL 6954.9 ‫ע‬ 555.5 ( ) after 24 h (data not shown). A549 cell viability, as den p 3 Induction of CXCL8 release from A549 cells by supernatants generated from different strains of exponentially growing Streptococcus pneumoniae. Confluent A549 monolayers grown in 24-well plates were incubated with supernatants generated from 10 8 cfu/mL of several different strains of S. pneumoniae, and levels of CXCL8 were measured in duplicate by ELISA. figure 2A) . Strain P369, a CbpAdeficient mutant of D39, produced no PCR product, confirming the deletion of the CbpA gene ( figure 2A) . SDS-PAGE analysis of concentrated supernatants generated from these strains of S. pneumoniae during exponential growth appropriately confirmed the presence (or absence) of clade A or clade B CbpA gene products ( figure 2B ). The anti-CbpA serum cross-reacted with PspA proteins ( figure 2B , open circles) also secreted by pneumococci. To distinguish cross-reactivity with PspA from direct reactivity with CbpA, a second, identical immunoblot was developed with specific anti-PspA serum that did not crossreact with CbpA (data not shown). CbpA bands could be identified through a comparison of the banding patterns. PspA bands were typically 75 kDa, whereas bands for CbpA were of a higher molecular mass, 85-140 kDa ( figure 2B ). The wide range of molecular masses covered by CbpA is caused by the heterogeneous nature of the cbpA gene. Both CbpA clades A and B contain an a-helical domain that consists of a conserved region and a hypervariable region that varies in length from strain to strain. Furthermore, all alleles contain choline-binding repeat domains, the number of which can vary from 4 to 11 repeats [13] . In general, clade A alleles are larger and contain an extra module that has homology to pspA alleles, whereas clade B alleles are smaller and lack this pspA-like domain. Stimulation of A549 cells with culture supernatants from the 6 wild-type strains consistently induced CXCL8 release (P ! , vs. negative control in each case). There were no significant .01 differences in CXCL8 production between invasive and nasopharyngeal isolates or among isolates of different CbpA clades (figure 3). The CbpA deletant mutant P369 also induced CXCL8 release, but the levels were 52% of those induced by the wild-type parent strain D39 ( ; figure 3) . P ! .01 Chemokine mRNA expression by A549 cells stimulated with recombinant CbpA. A549 cells were stimulated with 10 mg/mL recombinant clade B CbpA, 0.1 ng/mL IL-1a, or medium alone for 8 h, and the chemokine mRNA profile was examined by use of a commercial RNase protection assay. A549 cells constitutively expressed mRNA for CXCL8 and CCL2 (figure 4A). Treatment with 10 mg/mL recombinant CbpA caused a clear increase in mRNA levels for CXCL8 and CCL2, compared with that of unstimulated controls, but mRNA for CXCL10 (IP-10), XCL1 (Lymphotactin), CCL1 (I-309), CCL3 (MIP-1a), CCL4 (MIP1b), and CCL5 (RANTES) was not detected. Stimulation of A549 cells with 1.0 ng/mL IL-1a showed clear increases in mRNA for CXCL8, CXCL10, CCL2, and CCL5 (figure 4A). After stimulation with 10 mg/mL CbpA, mRNA expression for both CXCL8 and CCL2 increased markedly over an 8-h period, with increased levels of mRNA being clearly observed from 1.5 h onward ( figure 4B) .
Production of CXCL and CCL chemokines in response to recombinant CbpA. To establish whether A549 cells could produce other neutrophil-attracting, ELR-containing CXC chemokines in response to recombinant CbpA, we used ELISAs to measure the concentrations of CXCL1, CXCL5, CXCL8, and CCL2. Monolayers were stimulated with recombinant CbpA or recombinant PsaA (a 37-kDa virulence factor expressed on the surface of S. pneumoniae [10] ). IL-1a and untreated cells were used as controls. The concentrations of all 4 chemokines increased in a dose-dependent manner when stimulated with recombinant CbpA, but no increase above negative controls (data not shown) was seen with PsaA (figure 5), whereas IL-1a controls were found to be consistently positive (data not shown). A549 cell viability, as determined by propidium iodide and Hoechst 33428 staining, was typically 98% at the end of each stimulation experiment (data not shown).
A549 cell surface expression of ICAM-1 in response to recombinant CbpA. When A549 monolayers were stimulated with recombinant CbpA, the cell surface expression of ICAM-1 increased significantly, compared with that for unstimulated controls ( figure 6; ). This increase was dose dependent, with P ! .001 increasing concentrations of CbpA from 0.1 to 10 mg/mL (data not shown). Stimulation with 10 mg/mL PsaA did not increase ICAM-1 expression above background levels (figure 6).
Discussion
There is increasing evidence that airway epithelial cells play a key role in attracting neutrophils to sites of bacterial infection by secreting CXC chemokines in response to gram-negative bacteria or bacterial products [8, 9, [23] [24] [25] and that CXC chemokines also participate in the early recruitment of neutrophils in gram-positive pneumococcal infection [26] . In previous studies, A549 type II pulmonary alveolar epithelial cells have been shown to release CXCL8 in response to respiratory tract pathogens, including viruses, Mycoplasma species, and various other bacteria [27] [28] [29] [30] [31] . In this study, we demonstrate for the first time that secreted products of S. pneumoniae, in particular CbpA, induce expression of a range of both CXC and CC chemokines in human lung epithelial cells. Our observations extend those of Madsen et al. [19] , who demonstrated secretion of CXCL8 from A549 cells exposed to heat-killed pneumococci and secreted products, including CbpA. Supernatants generated from exponentially growing pneumococci elicited significantly more CXCL8 release than from heat-killed pneumococci of the same growth phase. This may be caused by heat-denaturation of bacterial cell surface proteins, which leads to loss of structural conformation and thus activity. In our hands, incubation of A549 cells with viable pneumococci did not induce CXCL8 release (data not shown) but resulted in extensive cell death (determined by viability staining) and disruption of the epithelial monolayers. This could explain the recent observation by Lagrou et al. [32] that cultured nasal epithelial cells do not secrete CXCL8 on stimulation with a type 23 invasive S. pneumoniae isolate.
We studied a range of common invasive and colonizing isolates of S. pneumoniae, including type 6b and type 14, as well as a standard laboratory stain of type 2 (D39) and its isogenic CbpA-deleted mutant. First, we determined the clade of CbpA expressed by each isolate. The cbpA clade A gene is larger than that of clade B, containing an extra region common to many pspA alleles. Supernatants from organisms of both clades induced similar CXCL8 production by A549 cells, which suggests that a region of CbpA that is identical in both clades is responsible for eliciting chemokine release. The source of different isolates (nasopharyngeal or invasive) also showed no obvious relationship with efficiency of chemokine induction. Supernatant from the CbpA-deficient mutant induced CXCL8 release that was reduced to 52% of that of the parent strain, which suggests that CbpA is not the only activator of CXCL8 release from A549 cells. Others could include CbpB-CbpJ or soluble pneumococcal cell-wall constituents, such as peptidoglycan, which has been shown to be bioreactive when released from either growing or antibiotic-killed bacteria [33, 34] .
We explored the range of chemokines induced in A549 cells by use of recombinant CbpA and a commercial RNase protection assay. We showed constitutive expression of CXCL8 and CCL2 in A549 cells, as described elsewhere [31, 35] . This could reflect roles for these chemokines in lung biology or may be a consequence of cell immortalization. CbpA stimulation resulted in active transcription of CXCL8 and CCL2 genes during an 8-h period, whereas CXCL10, XCL1, CCL1, and CCL3-5 mRNA was not detected at any time. Similarly, A549 cells infected with Mycobacterium tuberculosis produce mRNA and protein for CXCL8 and CCL2 but not for CCL3-5 [31] . IL-1a induced mRNA for CXCL8, CXCL10, CCL2, CCL4, and CCL5. Differences in chemokine gene expression in A549 cells have been seen in other studies. Tumor necrosis factor (TNF)-a stimulation of A549 cells induces expression of CCL2 and CCL5, whereas H 2 O 2 only induces expression of CCL2 [35] . There appear to be several distinct signaling pathways regulating transcription of chemokines in A549 cells.
We showed a corresponding increase in CXCL8 and CCL2 protein secretion by A549 cells in response to recombinant CbpA and release of 2 other ELR-containing chemokines, CXCL1 and CXCL5. Our results suggest that CbpA specifically up-regulates the transcription and production of neutrophil and monocyte and/or macrophage chemoattractants. Increased CXCL1 and CXCL8 preceding pulmonary neutrophil recruitment and CCL2 coinciding with macrophage infiltration has been shown in a murine model of pneumococcal pneumonia [36] . Alveolar macrophages release potent proinflammatory cytokines, such as IL-1 and TNF-a, upon binding to pneumococci [37] . It appears that CbpA may act in concert with proinflammatory cytokines during the early phases of pneumococcal respiratory infection to induce chemokines and thus phagocyte recruitment and release of other inflammatory mediators [38] . There are 140 human chemokines described to date. It is likely that others that have not been examined in our assay systems are induced by CbpA. Microarray technology will prove useful in pursuing this further.
The recombinant pneumococcal proteins that we used were developed in E. coli expression systems and could have become contaminated during isolation with gram-negative bacterial products, such as lipopolysaccharide or other cell-wall products known to activate A549 cells [39, 40] . The absence of chemokine induction by recombinant PsaA generated in an expression system identical to the recombinant CbpA used and the observation that preincubation of CbpA with the lipopolysaccharide inhibitor polymyxin did not reduce CXCL8 secretion (data not shown) suggests that such contamination was not responsible for our observations. Additionally, A549 cell viability, as determined by propidium iodide and Hoechst 33428 staining, was typically 98% at the end of each stimulation experiment (data not shown), which indicates that the recombinant CbpA preparation did not induce necrosis or apoptosis over the stimulation period.
ICAM-1 (CD54) is constitutively expressed by type I but not by type II alveolar epithelial cells [41] , but expression of ICAM-1 is up-regulated on type II cells in response to proinflammatory cytokines, such as IL-1a and TNF-a [35, 42] . ICAM-1 expression may be involved in alveolar macrophage and neutrophil movement over the epithelial surface [43] . Modulation of ICAM-1 expression by alveolar epithelial cells in response to S. pneumoniae in mice has been demonstrated elsewhere [44] . We demonstrate here that increased ICAM-1 expression by A549 cells in response to stimulation with recombinant CbpA. CbpA may have been the factor in type 1 pneumococcal supernatants responsible for the increased adhesion of activated neutrophils to A549 monolayers, as we have described elsewhere [20] . Type II epithelial cells appear to be the preferential targets for pneumococcal adherence in the alveolus [45] . Increased ICAM-1 expression could retain migrated neutrophils at the apical epithelial cell surface and promote pathogen clearance.
CbpA and other pneumococcal proteins, including PspA and pneumolysin, have been identified as potential vaccine candidates in murine studies [13, 22, 46] . Our observations that CbpA and other pneumococcal products may have wide-ranging and direct proinflammatory effects on the human respiratory system may prove pertinent to vaccine development studies.
